Synthalin dihydrochloride | CAS#301-15-5 | K+ channel blocker

MedKoo Cat#: 562037 | Name: Synthalin dihydrochloride

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Synthalin dihydrochloride is a K+ channel blocker.

Chemical Structure

Synthalin dihydrochloride

CAS#301-15-5

Theoretical Analysis

MedKoo Cat#: 562037

Name: Synthalin dihydrochloride

CAS#: 301-15-5

Chemical Formula: C12H30Cl2N6

Exact Mass: 328.1909

Molecular Weight: 329.31

Elemental Analysis: C, 43.77; H, 9.18; Cl, 21.53; N, 25.52

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Synthalin dihydrochloride; Synthalin 2HCl; BisG10; Riddobetes; Anticoman;

IUPAC/Chemical Name

2,2'-(decane-1,10-diyl)diguanidine

InChi Key

HJJOBGICUREWHC-UHFFFAOYSA-N

InChi Code

InChI=1S/C12H28N6.2ClH/c13-11(14)17-9-7-5-3-1-2-4-6-8-10-18-12(15)16;;/h1-10H2,(H4,13,14,17)(H4,15,16,18);2*1H

SMILES Code

N/C(N)=N/CCCCCCCCCC/N=C(N)/N.[H]Cl.[H]Cl

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 329.31 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Hackman JC, Holohean AM. The effects of polyamine agonists and antagonists on N-methyl-D-aspartate-induced depolarizations of amphibian motoneurons in situ. Brain Res. 2010 Apr 14;1325:10-8. doi: 10.1016/j.brainres.2010.02.025. Epub 2010 Feb 13. PubMed PMID: 20156426. 2: Mourer M, Dibama HM, Fontanay S, Grare M, Duval RE, Finance C, Regnouf-de-Vains JB. p-Guanidinoethyl calixarene and parent phenol derivatives exhibiting antibacterial activities. Synthesis and biological evaluation. Bioorg Med Chem. 2009 Aug 1;17(15):5496-509. doi: 10.1016/j.bmc.2009.06.040. Epub 2009 Jun 25. PubMed PMID: 19596201. 3: Grare M, Mourer M, Fontanay S, Regnouf-de-Vains JB, Finance C, Duval RE. In vitro activity of para-guanidinoethylcalix[4]arene against susceptible and antibiotic-resistant Gram-negative and Gram-positive bacteria. J Antimicrob Chemother. 2007 Sep;60(3):575-81. Epub 2007 Jul 10. PubMed PMID: 17626025. 4: Park HS, Yoon YM, Jung SJ, Kim CM, Kim JM, Kwak JH. Antistaphylococcal activities of CG400549, a new bacterial enoyl-acyl carrier protein reductase (FabI) inhibitor. J Antimicrob Chemother. 2007 Sep;60(3):568-74. Epub 2007 Jul 2. PubMed PMID: 17606482. 5: Dardonville C, Brun R. Bisguanidine, bis(2-aminoimidazoline), and polyamine derivatives as potent and selective chemotherapeutic agents against Trypanosoma brucei rhodesiense. Synthesis and in vitro evaluation. J Med Chem. 2004 Apr 22;47(9):2296-307. PubMed PMID: 15084128. 6: Allard B, Fournet G, Rougier O, Descans B, Vivaudou M. Dose-dependent activation and block by bisG10, a K+ channel blocker, of mouse and frog skeletal muscle KATP channels. FEBS Lett. 1995 Nov 20;375(3):215-9. PubMed PMID: 7498502. 7: Tattersall R. Traditional pharmacological management of non-insulin-dependent diabetes. Clin Invest Med. 1995 Aug;18(4):288-95. Review. PubMed PMID: 8549015. 8: Wang J, Best PM. Characterization of the potassium channel from frog skeletal muscle sarcoplasmic reticulum membrane. J Physiol. 1994 Jun 1;477(Pt 2):279-90. PubMed PMID: 7932219; PubMed Central PMCID: PMC1155628. 9: Allard B, Moutin MJ, Ronjat M. BisG10, a K+ channel blocker, affects the calcium release channel from skeletal muscle sarcoplasmic reticulum. FEBS Lett. 1992 Dec 7;314(1):81-4. PubMed PMID: 1333418. 10: Reynolds IJ. Interactions between zinc and spermidine on the N-methyl-D-aspartate receptor complex: clues to the mechanism of action of 1,10-bis(guanidino)decane and pentamidine. J Pharmacol Exp Ther. 1992 Nov;263(2):632-8. PubMed PMID: 1432693. 11: Reynolds IJ, Baron BM, Edwards ML. 1,10-bis(guanidino)decane inhibits N-methyl-D-aspartate responses in vitro and in vivo. J Pharmacol Exp Ther. 1991 Nov;259(2):626-32. PubMed PMID: 1658306. 12: Abramcheck CW, Best PM. Physiological role and selectivity of the in situ potassium channel of the sarcoplasmic reticulum in skinned frog skeletal muscle fibers. J Gen Physiol. 1989 Jan;93(1):1-21. PubMed PMID: 2915210; PubMed Central PMCID: PMC2216199. 13: Garcia AM, Miller C. Channel-mediated monovalent cation fluxes in isolated sarcoplasmic reticulum vesicles. J Gen Physiol. 1984 Jun;83(6):819-39. PubMed PMID: 6330279; PubMed Central PMCID: PMC2215664. 14: Ostenson CG. Effects of the biguanide synthalin A on the pancreatic A2-cell of the guinea pig. Exp Clin Endocrinol. 1983 May;81(3):255-62. PubMed PMID: 6350026. 15: Dave C, Ehrke MJ, Mihich E. Studies on the structure--activity relationship among aliphatic and aromatic bisguanylhydrazones and some related compounds. Chem Biol Interact. 1977 Jan;16(1):57-68. PubMed PMID: 837465. 16: Maina G, Mwehia N. Effects of synthalin on mitochondrial functions. Biochem Pharmacol. 1975 Feb 15;24(4):529-33. PubMed PMID: 234241. 17: Colson AM, Goffeau A, Briquet M, Weigel P, Mattoon JR. Nucleo-cytoplasmic interaction between oligomycin-resistant mutations in Saccharomyces cerevisiae. Mol Gen Genet. 1974;135(4):309-26. PubMed PMID: 4618887. 18: Langslow DR, Freeman BM. Investigations into the mode of action of synthalin A in Gallus domesticus. Comp Biochem Physiol A Comp Physiol. 1973 Nov 1;46(3):447-62. PubMed PMID: 4148981. 19: Langslow DR, Freeman BM, Buchanan KD. Responses of plasma glucose, free fatty acids, glucagon and insulin to synthalin A by Gallus domesticus. Comp Biochem Physiol A Comp Physiol. 1973 Nov 1;46(3):437-45. PubMed PMID: 4148980. 20: Himmelmann B, Kern HF. [Electron microscope studies on the effect of synthalin A on the islet system and adrenal gland of the duck]. Z Mikrosk Anat Forsch. 1971;83(3):369-87. German. PubMed PMID: 4327533.